Junfa Li Selected Research

Cysteine (L-Cysteine)

1/2020

SPARC Negatively Correlates With Prognosis After Transarterial Chemoembolization and Facilitates Proliferation and Metastasis of Hepatocellular Carcinoma via ERK/MMP Signaling Pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junfa Li Research Topics

Disease

18	Ischemic Stroke 10/2022 - 10/2013
17	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2022 - 01/2012
16	Infarction (Infarctions) 01/2020 - 04/2011
14	Wounds and Injuries (Trauma) 01/2020 - 04/2011
11	Pain (Aches) 01/2022 - 07/2007
9	Ischemia 08/2020 - 12/2007
9	Hypoxia (Hypoxemia) 12/2019 - 08/2005
7	Stroke (Strokes) 10/2022 - 06/2010
7	Postoperative Pain 01/2018 - 10/2009
6	Brain Ischemia (Cerebral Ischemia) 12/2019 - 04/2011
5	Hyperalgesia 10/2020 - 10/2009
3	Inflammation (Inflammations) 04/2021 - 08/2011
3	Edema (Dropsy) 03/2013 - 04/2011
2	Demyelinating Diseases (Demyelinating Disease) 10/2022 - 01/2021
2	Necrosis 04/2021 - 11/2015
2	Morphine Dependence 01/2021 - 01/2018
2	Hypersensitivity (Allergy) 01/2018 - 01/2018
2	Brain Injuries (Brain Injury) 01/2017 - 05/2011
2	Neoplasms (Cancer) 01/2017 - 07/2014
2	Body Weight (Weight, Body) 01/2017 - 12/2006
2	Glioma (Gliomas) 01/2017 - 03/2014
2	Ganglion Cysts (Ganglion) 01/2016 - 12/2007
2	Dehydration (Water Stress) 01/2007 - 08/2006
1	Pathologic Processes 04/2021
1	Chronic Pain 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2020
1	Liver Neoplasms (Liver Cancer) 01/2020
1	Lymphoma (Lymphomas) 01/2020
1	Carcinogenesis 01/2020

Drug/Important Bio-Agent (IBA)

31	Proteins (Proteins, Gene)FDA Link 10/2022 - 08/2005
17	Oxygen (Dioxygen)IBA 10/2022 - 02/2012
16	Glucose (Dextrose)FDA LinkGeneric 10/2022 - 10/2013
7	Protein Kinase CIBA 01/2018 - 06/2006
5	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 01/2010
5	Messenger RNA (mRNA)IBA 10/2020 - 01/2013
5	Remifentanil (Ultiva)FDA Link 01/2018 - 10/2009
5	Protein Isoforms (Isoforms)IBA 01/2018 - 06/2006
4	InterleukinsIBA 04/2021 - 06/2017
4	Interleukin-17 (Interleukin 17)IBA 01/2020 - 06/2017
4	Lidocaine (Xylocaine)FDA LinkGeneric 01/2018 - 10/2009
4	Propofol (Diprivan)FDA LinkGeneric 01/2017 - 10/2009
4	MicroRNAs (MicroRNA)IBA 09/2016 - 03/2012
4	p38 Mitogen-Activated Protein KinasesIBA 03/2013 - 08/2007
3	Analgesics (Analgesic Drugs)IBA 01/2021 - 01/2010
3	salicylhydroxamic acid (SHAM)IBA 10/2020 - 08/2013
3	Caspase 3 (Caspase-3)IBA 01/2020 - 11/2015
3	Small Interfering RNA (siRNA)IBA 01/2018 - 12/2017
3	Protein Kinases (Protein Kinase)IBA 05/2016 - 04/2007
3	2- (1- (3- dimethylaminopropyl)- 5- methoxyindol- 3- yl)- 3- (1H- indol- 3- yl)maleimideIBA 05/2011 - 01/2011
2	9- (benzoyloxy)- 2- (3- furanyl)dodecahydro- 6a,10b- dimethyl- 4,10- dioxo- 2H- naphtho(2,1- c)pyran- 7- carboxylic acid methyl esterIBA 04/2021 - 01/2017
2	Caveolin 1IBA 01/2021 - 10/2020
2	Ketamine FDA LinkGeneric 10/2020 - 01/2012
2	Monoclonal AntibodiesIBA 01/2020 - 02/2019
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2019 - 01/2017
2	CytokinesIBA 01/2019 - 08/2011
2	Therapeutic UsesIBA 01/2019 - 01/2019
2	AMPA Receptors (AMPA Receptor)IBA 01/2018 - 01/2011
2	PropionatesIBA 01/2018 - 01/2011
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2018 - 01/2018
2	triphenyltetrazoliumIBA 01/2018 - 08/2013
2	Synapsins (Synapsin I)IBA 01/2018 - 05/2011
2	GalaninIBA 02/2017 - 01/2017
2	Beclin-1IBA 12/2016 - 07/2014
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 01/2016 - 04/2013
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 01/2016 - 04/2013
2	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2016 - 08/2013
2	Retinaldehyde (Retinal)IBA 01/2016 - 12/2007
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 11/2015 - 10/2013
2	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 08/2007 - 07/2007
2	Large-Conductance Calcium-Activated Potassium Channels (Maxi-K Channels)IBA 01/2007 - 08/2006
1	NeuroliginsIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 04/2021
1	EnzymesIBA 04/2021
1	ImmunosorbentsIBA 04/2021
1	NLR ProteinsIBA 04/2021
1	Activin Receptors (Activin Receptor)IBA 01/2021
1	Luxol Fast Blue MBS (Luxol fast blue)IBA 01/2021
1	2',3'-Cyclic-Nucleotide Phosphodiesterases (2',3' Cyclic Nucleotide Phosphodiesterase)IBA 01/2021
1	4- (5- benzo(1,3)dioxol- 5- yl- 4- pyridin- 2- yl- 1H- imidazol- 2- yl)benzamideIBA 01/2021
1	activin AIBA 01/2021
1	Kainic Acid Receptors (Kainate Receptor)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Freund's AdjuvantIBA 10/2020
1	Antidepressive Agents (Antidepressants)IBA 10/2020
1	Sirtuin 1IBA 08/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2020
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 08/2020
1	Biological ProductsIBA 01/2020
1	Cysteine (L-Cysteine)FDA Link 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Complement Factor B (Factor B)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Matrix Metalloproteinases (MMPs)IBA 01/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2020
1	Caspase 12IBA 01/2020
1	Conditioned Culture MediaIBA 12/2019
1	Neuroprotective AgentsIBA 12/2019

Therapy/Procedure

3	Therapeutics 10/2022 - 04/2011
2	Anesthesia 01/2016 - 10/2009